Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Black, S.
Li, H.
McRae, T.
Richardson, S.
机构：
[1] Sunnybrook & Womens Coll, Toronto, ON, Canada
[2] Pfizer Inc, New York, NY USA
[3] Eisai Inc, Teaneck, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
    Black, S
    Li, HL
    McRae, T
    Richardson, S
    [J]. NEUROLOGY, 2006, 66 (05) : A347 - A347
  • [2] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Ohbayashi, Toshio
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
  • [3] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, placebo-controlled trial.
    Black, S
    Li, H
    McRae, T
    Richardson, S
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S71 - S71
  • [4] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    Rogers, SL
    Farlow, MR
    Doody, RS
    Mohs, R
    Friedhoff, LT
    Albala, B
    Baumel, B
    Booker, G
    Dexter, J
    Farmer, M
    Feighner, JP
    Ferris, S
    Gordon, B
    Gorman, DG
    Hanna, G
    Harrell, LE
    Hubbard, R
    Kennedy, J
    McCarthy, J
    Scharre, DW
    Schaerf, F
    Schneider, L
    Seltzer, B
    Siegal, A
    Stark, SR
    Strauss, A
    Walshe, TM
    [J]. NEUROLOGY, 1998, 50 (01) : 136 - 145
  • [5] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease - Pilot Study
    Prasher, VP
    Huxley, A
    Haque, MS
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (03) : 270 - 278
  • [6] A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    [J]. NEUROLOGY, 2001, 57 (04) : 613 - 620
  • [7] Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
    Roman, GC
    Pratt, RD
    Perdomo, CA
    Perdomo, CA
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S55 - S55
  • [8] Donepezil improves cognitive function in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
    Pratt, RD
    Perdomo, CA
    [J]. NEUROLOGY, 2002, 58 (07) : A161 - A162
  • [9] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bolliger, Chris T.
    Issa, Jaqueline S.
    Posadas-Valay, Rodolfo
    Safwat, Tarek
    Abreu, Paula
    Correia, Eurico A.
    Park, Peter W.
    Chopra, Pravin
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477
  • [10] A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer's Disease
    Burns, Alistair
    Perry, Elaine
    Holmes, Clive
    Francis, Paul
    Morris, Julie
    Howes, Melanie-Jayne R.
    Chazot, Paul
    Lees, George
    Ballard, Clive
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (02) : 158 - 164
12345